Burning Rock Biotech (BNR) Beginning Cash Balance (2019 - 2025)

Burning Rock Biotech's Beginning Cash Balance history runs 7 years deep, the most recent figure standing at $66.8 million for Q4 2025.

• In Q4 2025, Beginning Cash Balance fell 2.17% year-over-year to $66.8 million; the TTM figure through Dec 2025 stood at $275.5 million (down 13.88% YoY), while the FY2025 annual figure was $74668.0, down 11.41% from the prior year.
• Beginning Cash Balance was $66.8 million for Q4 2025 at Burning Rock Biotech, up from $63.9 million in the prior quarter.
• In the past five years, Beginning Cash Balance ranged from a high of $327.2 million in Q2 2021 to a low of $63.9 million in Q3 2025.
• Historically, Beginning Cash Balance has averaged $149.6 million across 5 years, with a median of $105.6 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Beginning Cash Balance surged 1987.38% in 2021, then slumped 57.02% in 2023.
• A 5-year view of Beginning Cash Balance shows it stood at $258.9 million in 2021, then fell by 19.4% to $208.7 million in 2022, then plunged by 57.02% to $89.7 million in 2023, then fell by 23.89% to $68.3 million in 2024, then fell by 2.17% to $66.8 million in 2025.
• The last three Beginning Cash Balance figures came in at $66.8 million (Q4 2025), $63.9 million (Q3 2025), and $72.9 million (Q2 2025), per Business Quant data.